Day SM - Search Results

1

A nonhuman primate model of human non-suicidal self-injury: serotonin-transporter genotype-mediated typologies.

Wood EK, Kruger R, Day JP, Day SM, Hunter JN, Neville L, Lindell SG, Barr CS, Schwandt ML, Goldman D, Suomi SJ, Harris JC, Higley JD. Wood EK, et al. Among authors: day jp, day sm. Neuropsychopharmacology. 2022 May;47(6):1256-1262. doi: 10.1038/s41386-021-00994-8. Epub 2021 Apr 14. Neuropsychopharmacology. 2022. PMID: 33854202 Free PMC article.

2

Social inequalities in health in nonhuman primates.

Shively CA, Day SM. Shively CA, et al. Among authors: day sm. Neurobiol Stress. 2014 Nov 20;1:156-63. doi: 10.1016/j.ynstr.2014.11.005. eCollection 2015 Jan. Neurobiol Stress. 2014. PMID: 27589665 Free PMC article. Review.

3

Mediterranean diet, stress resilience, and aging in nonhuman primates.

Shively CA, Appt SE, Chen H, Day SM, Frye BM, Shaltout HA, Silverstein-Metzler MG, Snyder-Mackler N, Uberseder B, Vitolins MZ, Register TC. Shively CA, et al. Among authors: day sm. Neurobiol Stress. 2020 Oct 19;13:100254. doi: 10.1016/j.ynstr.2020.100254. eCollection 2020 Nov. Neurobiol Stress. 2020. PMID: 33344709 Free PMC article.

4

Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design.

Ruggiero AD, Vemuri R, Blawas M, Long M, DeStephanis D, Williams AG, Chen H, Justice JN, Macauley SL, Day SM, Kavanagh K. Ruggiero AD, et al. Among authors: day sm. Geroscience. 2023 Oct;45(5):2785-2803. doi: 10.1007/s11357-023-00830-5. Epub 2023 Jun 1. Geroscience. 2023. PMID: 37261678 Free PMC article.

5

Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease.

Day SM, Ma T. Day SM, et al. Neurosci Bull. 2019 Oct;35(5):934-936. doi: 10.1007/s12264-019-00355-y. Epub 2019 Mar 7. Neurosci Bull. 2019. PMID: 30843143 Free PMC article. Review. No abstract available.

6

Ethanol exposure alters Alzheimer's-related pathology, behavior, and metabolism in APP/PS1 mice.

Day SM, Gironda SC, Clarke CW, Snipes JA, Nicol NI, Kamran H, Vaughan W, Weiner JL, Macauley SL. Day SM, et al. Neurobiol Dis. 2023 Feb;177:105967. doi: 10.1016/j.nbd.2022.105967. Epub 2022 Dec 16. Neurobiol Dis. 2023. PMID: 36535550 Free PMC article.

7

Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.

Day SM, Yang W, Wang X, Stern JE, Zhou X, Macauley SL, Ma T. Day SM, et al. eNeuro. 2019 May 15;6(2):ENEURO.0031-19.2019. doi: 10.1523/ENEURO.0031-19.2019. Print 2019 Mar/Apr. eNeuro. 2019. PMID: 31040160 Free PMC article.

8

Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.

Beckelman BC, Day S, Zhou X, Donohue M, Gouras GK, Klann E, Keene CD, Ma T. Beckelman BC, et al. J Alzheimers Dis. 2016 Sep 6;54(2):669-78. doi: 10.3233/JAD-160036. J Alzheimers Dis. 2016. PMID: 27567813 Free PMC article.

9

Glucagon-like peptide-1 cleavage product GLP-1 (9-36) amide enhances hippocampal long-term synaptic plasticity in correlation with suppression of Kv4.2 expression and eEF2 phosphorylation.

Day SM, Yang W, Ewin S, Zhou X, Ma T. Day SM, et al. Hippocampus. 2017 Dec;27(12):1264-1274. doi: 10.1002/hipo.22795. Epub 2017 Aug 30. Hippocampus. 2017. PMID: 28833775 Free PMC article.

10

Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys.

Kavanagh K, Day SM, Pait MC, Mortiz WR, Newgard CB, Ilkayeva O, Mcclain DA, Macauley SL. Kavanagh K, et al. Among authors: day sm. Front Neurosci. 2019 Aug 28;13:843. doi: 10.3389/fnins.2019.00843. eCollection 2019. Front Neurosci. 2019. PMID: 31555072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page